| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/16/2010 | CA2261334C Bovine polynucleotide vaccine for the intradermal route |
| 11/16/2010 | CA2215529C Carbohydrate-based vaccine and diagnostic reagent for trichinosis |
| 11/15/2010 | CA2678775A1 Protein markers useful to differentiate immunized and infected specimens |
| 11/11/2010 | WO2010129959A1 Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna germline antibodies |
| 11/11/2010 | WO2010129947A2 Alpha thymosin peptides as vaccine enhancers |
| 11/11/2010 | WO2010129917A2 Anti-cd100 antibodies and methods for using the same |
| 11/11/2010 | WO2010129904A1 Humanized anti-egfl7 antibodies and methods using same |
| 11/11/2010 | WO2010129895A2 Cd133 epitopes |
| 11/11/2010 | WO2010129674A2 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 11/11/2010 | WO2010129670A2 Method for modulating angiogenesis using fibromodulin |
| 11/11/2010 | WO2010129578A1 E. coli lpfa antigen for prevention and treatment of infectious diseases |
| 11/11/2010 | WO2010129553A1 S1p3 receptor inhibitors for treating conditions of the eye |
| 11/11/2010 | WO2010129537A1 Phosphopeptides as melanoma vaccines |
| 11/11/2010 | WO2010129515A1 Modulation of the tgf-beta and pi3k/akt pathways in the diagnosis and treatment of squamous cell carcinoma |
| 11/11/2010 | WO2010129469A1 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies |
| 11/11/2010 | WO2010129457A2 Vaccines against tularemia |
| 11/11/2010 | WO2010129304A2 Method for making heteromultimeric molecules |
| 11/11/2010 | WO2010128398A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability |
| 11/11/2010 | WO2010128364A1 Method for the prevention or treatment of taxodiaceae pollen allergy |
| 11/11/2010 | WO2010128338A2 Vaccines |
| 11/11/2010 | WO2010128100A1 Method for producing virus from cell culture involving homogenization |
| 11/11/2010 | WO2010128092A1 ANTI-IL1-β ANTIBODY COMBINATION THERAPY |
| 11/11/2010 | WO2010128053A1 Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases |
| 11/11/2010 | WO2010127784A1 Polypeptide derived from enterococcus and its use for vaccination |
| 11/11/2010 | WO2010127492A1 Recombinant bcg vaccine rbcg::xb |
| 11/11/2010 | WO2010127420A1 Genetically modified sequences encoding plasmodium vivax antigens |
| 11/11/2010 | WO2010127400A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb) |
| 11/11/2010 | WO2010127398A1 Plasmodial polynucleotides, proteins and uses thereof |
| 11/11/2010 | WO2010108048A3 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins |
| 11/11/2010 | WO2010106542A3 USE OF NKp46 FOR PREVENTING DIABETES |
| 11/11/2010 | WO2010102276A3 Humanized anti-cd19 antibody formulations |
| 11/11/2010 | WO2010093705A3 Synthetic rna-based agonists of tlr7 |
| 11/11/2010 | WO2010074540A3 Pharmaceutical composition containing an anionic drug, and a production method therefor |
| 11/11/2010 | WO2010053559A9 Mesothelin antibody protein fusions and methods of use |
| 11/11/2010 | WO2007133835A8 Ras mutation and compositions and methods related thereto |
| 11/11/2010 | WO2007077487A3 Method and device for transdermal immunization |
| 11/11/2010 | US20100287637 Methods of blocking tissue destruction by autoreactive t cells |
| 11/11/2010 | US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations |
| 11/11/2010 | US20100287630 Models for vaccine assessment |
| 11/11/2010 | US20100286774 Artificial eardrum using silk protein and method of fabricating the same |
| 11/11/2010 | US20100286384 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 11/11/2010 | US20100286375 Carrier molecules |
| 11/11/2010 | US20100286362 Mammalian MDM2 Binding Proteins and Uses Thereof |
| 11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
| 11/11/2010 | US20100285139 Pharmaceutical composition for the prophylaxis and/or symptomatic treatment of cystic fibrosis |
| 11/11/2010 | US20100285135 Nanoparticles For Use In Immunogenic Compositions |
| 11/11/2010 | US20100285132 Immunotherapy compositions, method of making and method of use thereof |
| 11/11/2010 | US20100285109 Truncated secretory aspartyl proteinase 2 |
| 11/11/2010 | US20100285108 Method for therapeutic use |
| 11/11/2010 | US20100285107 Short nucleic acid molecule-mediated modulation of aurora b kinase expression and combinations for use in anticancer therapy |
| 11/11/2010 | US20100285106 Multicomponent vaccine |
| 11/11/2010 | US20100285099 Vaccination by transcutaneous targeting |
| 11/11/2010 | US20100285094 Polymeric compositions and methods of making and using thereof |
| 11/11/2010 | US20100285071 Purification of her-2 variants |
| 11/11/2010 | US20100285070 Polynucleotides of haemophilus parasuis and its use |
| 11/11/2010 | US20100285069 Meningococcal vaccine formulations |
| 11/11/2010 | US20100285068 Method for the internalization of non-invasive bacteria in eukaryote cells |
| 11/11/2010 | US20100285067 Interferon-beta production modulating listeria strains and methods for using same |
| 11/11/2010 | US20100285066 Canine leishmania vaccine |
| 11/11/2010 | US20100285065 Modified cea nucleic acid and expression vectors |
| 11/11/2010 | US20100285064 Adjuvant composition for vaccine |
| 11/11/2010 | US20100285063 Novel canine influenza virus and vaccine therefore |
| 11/11/2010 | US20100285062 Combined mucosal and parenteral immunization against hiv |
| 11/11/2010 | US20100285061 Dna vaccination protocols |
| 11/11/2010 | US20100285060 Alpha thymosin peptides as vaccine enhancers |
| 11/11/2010 | US20100285059 Cytomegalovirus Vaccines and Methods of Production |
| 11/11/2010 | US20100285058 Dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein |
| 11/11/2010 | US20100285057 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 11/11/2010 | US20100285056 Baculovirus-Based Vaccines |
| 11/11/2010 | US20100285055 Activation of natural killer (NK) cells and methods of use |
| 11/11/2010 | US20100285052 Chemically Programmable Immunity |
| 11/11/2010 | US20100285051 Vaccine |
| 11/11/2010 | US20100285050 Compositions and Methods |
| 11/11/2010 | US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 11/11/2010 | US20100285048 Use of flagellin in the immunotherapy of yersinia pestis |
| 11/11/2010 | US20100285047 Therapeutics and diagnostics for group a streptococci |
| 11/11/2010 | US20100285046 Nontoxic ricin mutant compositions and methods |
| 11/11/2010 | US20100285045 Novel Neurotrophic Factor Protein and Uses Thereof |
| 11/11/2010 | US20100285044 Method and compositions for treatment of cancers |
| 11/11/2010 | US20100285043 Mite antigenic rice |
| 11/11/2010 | US20100285042 Methods of enhancing adjuvaticity of vaccine compositions |
| 11/11/2010 | US20100285041 Class A Oligonucleotides with Immunostimulatory Potency |
| 11/11/2010 | US20100285040 Methods of enhancing immune response using electroporation-assisted vaccination and boosting |
| 11/11/2010 | US20100285039 B7-H1 (CD274) Antagonists Induce Apoptosis of Tumor Cells |
| 11/11/2010 | US20100285038 Factor Involved in Metastasis and Uses Thereof |
| 11/11/2010 | US20100285037 Antibodies to cll-1 |
| 11/11/2010 | US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same |
| 11/11/2010 | US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 |
| 11/11/2010 | US20100285034 Method |
| 11/11/2010 | US20100285033 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 11/11/2010 | US20100285032 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 11/11/2010 | US20100285031 Hox Compositions and Methods |
| 11/11/2010 | US20100285030 Antibodies to Ox-2/Cd200 and Uses Thereof |
| 11/11/2010 | US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies |
| 11/11/2010 | US20100285028 Methods of treating coagulopathy |
| 11/11/2010 | US20100285027 Antibodies specific for human hepcidin |
| 11/11/2010 | US20100285026 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 11/11/2010 | US20100285025 Antibodies specific for the c-terminal regulatory domain of egfr and their use |
| 11/11/2010 | US20100285024 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 11/11/2010 | US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer |